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Abstract — Recent studies suggest that patients with psychiat-
ric disorders tend to do worse than patients without a psychiatric 
diagnosis when undergoing total hip arthroplasty (THA) or total 
knee arthroplasty (TKA). Whether this is due to their psychiatric 
condition, pharmacological treatment, a combination of the two, 
or something else has not been thoroughly analyzed—and there 
are no internationally accepted guidelines for perioperative man-
agement of psychiatric patients. This overview summarizes our 
current knowledge on perioperative risks in patients with preop-
erative psychiatric disorders and the possible role of psychotropic 
drugs in the perioperative course. This will be useful when plan-
ning future strategies for improvement of surgical outcome fol-
lowing hip and knee arthroplasty.
■
Preoperative prediction of surgical risk is essential in order to 
apply strategies for reduction of postoperative morbidity and 
convalescence. The concept of fast-track surgery has evolved 
across various procedures including hip and knee replacement 
(Kehlet 2013), and has repeatedly been demonstrated to reduce 
length of hospital stay and morbidity (Kehlet 2013, Khan et al. 
2014). It may therefore be questioned whether classical preop-
erative risk factors (Kehlet and Mythen 2011) are still appro-
priate when a fast-track care program has been initiated. Thus, 
recent studies on fast-track hip and knee replacement have 
suggested that preoperative functional status, cardiopulmo-
nary disease, smoking and alcohol use, and diabetes may now 
have less of an effect on outcome than previously believed 
(Jørgensen and Kehlet 2013, Holm et al. 2014, Jørgensen et al. 
2015A). In most preoperative risk indices, psychiatric condi-
tions and diseases and also the use of psychopharmacological 
drug treatment are rarely taken account of. This may be due 
to a lack of data, except in patients with serious mental ill-
ness (Huyse et al. 2006, Copeland et al. 2008, Bot et al. 2014, 
Menendez et al. 2014). Some large retrospective database 
studies in hip and knee arthroplasty have shown confl icting 
results (Stundner et al. 2013, Buller et al. 2015). In contrast, 
a recent large prospective study has suggested that psychi-
atric disorders and the use of psychopharmacological treat-
ment may be more important risk factors in fast-track hip and 
knee arthroplasty than conventional risk factors by prolonging 
length of stay (LOS), re-admissions, and morbidity (Jørgensen 
et al. 2015B). Given the well-established high incidence of 
psychiatric disease including depression, bipolar disorders, 
schizophrenia, and anxiety (Olsen et al. 2004, Somers et al. 
2006, Clemente et al. 2015), concentrating more on periop-
erative management of psychiatric patients is both relevant 
and timely. For this reason, we present a narrative overview of 
the current state of knowledge concerning psychiatric disease 
and psychopharmacological therapy as risk factors in fast-
track hip and knee replacement. We provide an update on the 
specifi c role of psychiatric disease and the role of the effects 
of psychotropic drugs and any side effects in relation to the 
perioperative period. Secondly, we outline strategies for future 
research and clinical practice.
Psychotropic drugs
Distinction between the psychiatric disease itself and the side 
effects of psychotropic drugs is a challenge when evaluating 
perioperative outcomes, raising the question of the relative 
importance of disease-related factors and drug-related factors 
and their independent effects on surgical outcome. Use of psy-
chopharmacological drugs was prevalent in about 12% of a 
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recent Danish cohort for hip and knee arthroplasty (Jørgensen 
et al. 2015B), but this is seldom considered in preoperative 
assessment. Furthermore, there are no evidence-based guide-
lines for psychotropic drugs in the perioperative period, and 
there is little documentation (Huyse et al. 2006, Strauss 2014). 
Few studies have focused on the drug-related effects, although 
some authors have suggested reasonable perioperative drug 
management strategies (Kudoh 2005, Huyse et al. 2006, Attri 
et al. 2012, Strauss 2014). Although generally inconclusive, 
such studies have highlighted the complex and multidisci-
plinary decision-making process when administering psycho-
tropics perioperatively. 
Distinguishing between the effects of psychotropic drugs 
and the psychiatric disease itself is diffi cult, even in non-sur-
gical psychiatric patients, as several common postoperative 
outcome measures (e.g. falls and gastrointestinal bleeding) 
are already over-represented in patients treated with selective 
serotonin re-uptake inhibitors (SSRIs) in general (Coupland et 
al. 2011). In fact, a recent review has questioned the benefi cial 
effects of long-term use of psychotropics altogether (Gotzsche 
et al. 2015)
In addition, factors such as the extent of surgery, anesthe-
sia, the direct and indirect effects of psychotropics, the risk of 
withdrawal symptoms, and the risk of psychiatric relapse are 
worth considering when deciding whether or not to discon-
tinue any psychotropic drug treatment preoperatively (Attri 
et al. 2012). However, some drugs have been given more 
attention than others. The SSRIs, which are some of the most 
common drugs for treating depression and anxiety, have been 
under scrutiny for their antiplatelet activity. Several studies 
have indicated that SSRIs enhance the risk of perioperative 
bleeding, most notably gastrointestinal bleeding related to 
mucosal injury (Looper 2007, Andrade et al. 2010, Yamamoto 
et al. 2010, Coupland et al. 2011). Increased perioperative 
bleeding has also been demonstrated in orthopedic patients 
treated with SSRIs (Movig et al. 2003, van Haelst et al. 2010), 
although the clinical relevance is uncertain (Shepherd et al. 
2015). Generally, preoperative discontinuation of SSRIs is not 
recommended—due to risk of discontinuation syndrome and 
relapse (Huyse et al. 2006, van Haelst et al. 2010, Attri et al. 
2012). Study results are confl icting regarding perioperative 
management of tricyclic anti-depressants (TCAs) (Huyse et al. 
2006, Attri et al. 2012, Strauss 2014), but there is agreement 
that monoamine oxidase inhibitors (MAOIs) can be continued 
throughout the perioperative period. Lithium, which is also a 
mood-stabilizing drug used in the treatment of depression and 
bipolar disorder, has some adverse effects on the kidney and 
therefore poses a risk in the perioperative period. Routine dis-
continuation is therefore recommended before surgery (Huyse 
et al. 2006, Attri et al. 2012). Regarding anti-psychotics, the 
benefi ts of continuing outweigh the risks and routine discon-
tinuation is not recommended (Kudoh 2005, Attri et al. 2012, 
Strauss 2014).  
Patient- and disease-related factors
Factors that relate to the patient’s psychiatric status have been 
shown to affect surgical outcome (Bressi et al. 2006, Abrams 
et al. 2010, Maeda et al. 2014). A negative association has 
been found for numerous outcomes (see below) and psychi-
atric disease has been recognized as being an independent 
risk factor in perioperative management (Bryson and Kellner 
2014).
Importantly, this high-risk population already has a signifi -
cantly shorter life expectancy (Roshanaei-Moghaddam and 
Katon 2009, Tiihonen et al. 2009, Laursen 2011, Chesney et 
al. 2014, Ringen et al. 2014, Kessing et al. 2015), except for 
those with anxiety (Saeed Mirza et al. 2015), mainly due to the 
high prevalence of concomitant physical comorbidity (Correll 
et al. 2015). Poor lifestyle choices and disparities in access to, 
utilization of, and provision of healthcare have been pointed 
out as primary causes (De Hert et al. 2011). 
Poorer outcomes may also apply to hip and knee arthro-
plasty patients with psychiatric comorbidity. Reports on 
increased LOS, non-routine discharge, perioperative morbid-
ity, periprosthetic infection rate, mortality rate, surgery-related 
re-admission rate, risk of falling, and increased perioperative 
bleeding (van Haelst et al. 2010, Bozic et al. 2012B, Stundner 
et al. 2013, Buller et al. 2015, Jørgensen et al. 2015B) are all 
causes for concern. Given the relatively large physical comor-
bidity burden of these patients, suboptimal outcomes may be 
expected. One large prospective study has shown a signifi cant 
increase in perioperative morbidity, surgery-related 90-day 
re-admissions, and falling—after adjusting for various estab-
lished confounders (Jørgensen et al. 2015B).  Furthermore, 
all psychopharmacological subgroups had an equal effect on 
the above-mentioned surgical outcomes, thus suggesting that 
SSRIs, other anti-depressants, and anti-psychotics are equiva-
lent in this respect. One alternative is that the psychiatric dis-
ease itself is fully or partly responsible for the suboptimal sur-
gical outcomes. 
Patient-reported outcome measures (PROMs)
Studies have suggested that between 11% and 20% of patients 
who undergo hip or knee arthroplasty are dissatisfi ed with 
regard to pain relief, limited function, or the overall outcome 
(Rolfson et al. 2011, Drexler et al. 2013, Dunbar et al. 2013, 
Nam et al. 2014). This is based on health reports given directly 
by the patients involved in the studies with no intermediate 
interpretations from others—so-called patient-reported out-
come measures (PROMs) (Rolfson and Malchau 2015). 
PROMs are receiving growing attention because they might 
give us a clue as to what is different about these dissatisfi ed 
patients, enabling surgeons to identify patients who are less 
likely to benefi t from surgery. It has been shown that low self-
reported mental health status preoperatively results in poorer 
subjective outcome (Fisher et al. 2007, Vissers et al. 2012, 
Khatib et al. 2015), thus suggesting that pre-existing psycho-
logical factors have an effect on PROMs.
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On the other hand, several studies have also suggested 
that THA and TKA may even serve to alleviate anxiety 
and depressive symptoms (Papakostidou et al. 2012, Duiv-
envoorden et al. 2013, da Silva et al. 2014). This benefi cial 
psychological effect is thought to stem from the close rela-
tion between chronic pain (as in osteoarthritis) and depres-
sive states (Giesecke et al. 2005, Papakostidou et al. 2012). 
Finally, a group of patients exhibit “pain catastrophizing”, 
where intense and excessive concentration on pain sensa-
tions preoperatively is associated with a higher risk of persis-
tent pain and an overall worse functional outcome after TKA 
(Riddle et al. 2010, Vissers et al. 2012, Khatib et al. 2015). 
Overall, these psychological factors are considered to be 
modifi able, so preoperative assessment of mental health in 
THA and TKA candidates may have the potential to improve 
surgical outcome (Khatib et al. 2015, Rolfson and  Malchau 
2015). 
Problems of study design
Most studies conducted on surgical outcome after hip and 
knee arthroplasty in psychiatric patients have been retrospec-
tive administrative database studies (Bozic et al. 2012A, B, 
Stundner et al. 2013, Bozic et al. 2014, Browne et al. 2014, 
Buller et al. 2015), and have therefore involved several inher-
ent limitations. First of all, most authors have defi ned psychi-
atric disease based on diagnostic coding. This is problematic, 
as patients without these codes—yet treated with psychotropic 
drugs—may be included in the control group, thus masking 
the true infl uence of psychiatric disease on outcomes. Fur-
thermore, there is a risk of misclassifi cation when diagnos-
tic coding provides all the data regarding diagnosis, adverse 
events, and procedures. Secondly, most of these large database 
studies only provide in-hospital data. Consequently, potential 
surgery-related re-admissions and other post-discharge events 
may not be represented. Thirdly, no or very little information 
regarding perioperative care is available, which complicates 
interpretation. This is important, as perioperative care for 
THA and TKA patients has evolved dramatically in recent 
years (Husted et al. 2012), while most database studies cover 
long periods of time dating back to before fast-track surgery 
was the standard of care.
One recent prospective study with detailed and complete 
90-day follow-up was based on a preoperative questionnaire 
(Jørgensen et al. 2015B) and was cross-referenced to a nation-
wide database on dispensed prescriptions. Although patients 
who self-reported a preoperative psychiatric disorder had 
higher postoperative morbidity, there may be a risk of under-
reporting when using questionnaires, although this was com-
pensated for by cross-referencing to dispensed psychotropic 
drugs. Also, no information on psychiatric diagnoses or indi-
cation for psychopharmacological treatment was available, 
thus preventing conclusions from being reached regarding the 
role of specifi c psychiatric diagnoses. 
Future strategies
Recent fi ndings have demonstrated increased LOS, re-admis-
sions, and morbidity in THA and TKA patients with psychi-
atric disease. These fi ndings are likely to have an important 
impact on clinical practice because of their scope and severity, 
so a more thorough and individualized preoperative evalua-
tion of psychiatric patients seems a reasonable strategy. Con-
sequently, some patients might be deemed unfi t for surgery 
or be allocated to an optimized fast-track involving a more 
vigilant postoperative regime. 
More detailed prospective studies in a well-defi ned fast-
track setting are needed to enhance our understanding of the 
covariates that infl uence the perioperative course of these 
patients. Such studies should concentrate on clarifying the 
complex relationship between psychotropic drugs and psychi-
atric disease as combined or independent risk factors. 
Discussion
This overview of the literature shows that there is a limited 
amount of knowledge regarding the interaction between the 
THA or TKA patient and pre-existing psychiatric disorders 
or treatments.
Although the studies that have been carried out suggest a 
complex interaction between psychiatric comorbidity and 
psychotropic drugs, the question regarding “patient or drug?” 
remains unanswered. In particular, there is no detailed infor-
mation regarding severity of the specifi c psychiatric diagno-
ses and psychopharmacological treatment. Such information 
could refi ne the above-mentioned question from its simple 
“either/or” form, hopefully resulting in a more balanced 
research approach.  
More detailed studies in the fast-track setting are therefore 
required to address these questions, especially regarding seri-
ous adverse events such as falls and infections. It is crucial 
that such studies should provide information for strategies for 
improvement, as previous results suggest that a change in peri-
operative management is appropriate for this group of high-
risk patients (Jørgensen et al. 2015B). 
Beyond the immediate postoperative period, the principal 
aims of arthroplasty are pain relief and improved function. 
Pre-existing psychological factors also have an effect on these 
important outcomes, which could infl uence future patient 
selection, preoperative education, and timing of surgery in an 
effort to enhance the proportion of patients who benefi t from 
THA and TKA.
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